期刊文献+

EphA2 siRNA转染对人卵巢癌细胞SKOV3生物学行为的影响

Influence of EphA2 siRNA Transfection on the Biological Behavior of Human Ovarian Carcinoma Cell
原文传递
导出
摘要 目的探讨促红素人肝细胞受体酪氨酸激酶A2(EphA2)干扰性小RNA(siRNA)转染人卵巢癌细胞SKOV3后,对其生物学行为的影响。方法根据EphA2序列合成一对siRNA,转染SKOV3细胞,通过荧光倒置显微镜观察转染效率和细胞形态;Western blot检测EphA2蛋白表达水平;台盼蓝染色细胞计数法绘制细胞生长曲线;集落形成实验、黏附力测定、细胞侵袭重建基底膜实验测定细胞的集落形成率、黏附和侵袭力。结果构建的EphA2siRNA转染SKOV3后,荧光倒置显微镜下可见大量荧光颗粒;Western blot检测EphA2蛋白水平表达降低(P<0.05);细胞的增殖、黏附力、侵袭力均受到抑制(P<0.05);集落形成率无明显影响(P>0.05)。结论 EphA2siRNA有效降低细胞中EphA2基因表达,抑制细胞的增殖,降低细胞的黏附力和侵袭力,从而逆转其恶性生物学行为,为肿瘤的有效干预和治疗提供新的靶点。 Objective To explore EphA2 siRNA transfection and its influence on the biological behavior of human ovarian carcinoma cells. Methods One pairs of siRNA was synthesized and transfected into the human ovarian carcinoma cell line SKOV3. Observation of the transfeetion efficiency through the fluorescence inverted microscope was followed by the evaluation of expression of EphA2 protein using Western blot. The effects of F.phA2 siRNA on proliferation of SKOV3 cells were observed by drawing cell growth curves and measuring cloning efficiency, and the adhesion and invasion of SKOV3 were detected by cell adhesion assay and Matrigel-boyden chamber method respectively. Results After successful transfection, a large number of fluorescent particles were observed under the fluorescence inverted microscope. The expression of EphA2 protein was obviously suppressed by EphA2 siRNA (P(0.05), The cell proliferation, adhesiveness and invasiveness were significantly inhibited (P〈 0.05). However, no changes in colony-forming efficiency were observed (P〉0.05). Conclusion Down-regulation of EphA2 gene by EphA2 siRNA in SKOV3 cell line showed retardation of ceil growth, proliferation and partial reversion of the malignant phenotype, including the ability of adhesion and invasion. EphA2 may be a new and potent target of gene therapy in ovarian carcinoma.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2013年第6期877-881,共5页 Journal of Sichuan University(Medical Sciences)
关键词 EPHA2 干扰性小RNA SKOV3 细胞侵袭力 细胞增殖 EphA2 Small interfering RNA SKOV3 Cell invasiveness Cell proliferation
  • 相关文献

参考文献19

  • 1Walker-Daniels J,Hess AR,Hendrix MJ,et al.Differentialregulation of EphA2 in normal and malignant cells.Am JPathol,2003; 162(4):1037-1042.
  • 2Karidis NP,Giaginis C,Tsourouflis G,et al.Eph-A2 andEph-A4 expression in human benign and malignant thyroidlesions,an immunohistochemical study.Med Sci Monit,2011;17C9):BR257-BR265.
  • 3Liu Y,Yu CY,Qiu YZ,et al.Downregulation of EphA2expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.JCancer Res Clin Oncol,2012; 138(3):195-202.
  • 4韩丽萍,刘娟芳,刘香荣,董子明,索振河.EphA2受体及其配体在浆液性卵巢癌中的表达及其临床意义[J].四川大学学报(医学版),2011,42(2):179-184. 被引量:2
  • 5Haft L,Dong Z,Qiao Y,et al.The clinical significance ofEphA2 and Ephrin A-I in epithelial ovarian carcinomas.Gynecol Oncol,2005,99(2):278-286.
  • 6Klein R.Excitatory Eph receptors and adhesive ephrin ligands.Curr Opin Cell Biol,2001; 13(2):196-203.
  • 7Sulman EP,Tang XX,Allen C,et al.ECK,a human eph-related gene,maps to lp36.I,a common region of alteration inhuman cancers.Genomics? 1997;40(2):371-374.
  • 8Miao H,Wei BR,Peehl DM,et al.Activation of EphAreceptor tyrosine kinase inhibits the Ras/MAPK pathway.NatCell Biol,2001;3(5):527-530.
  • 9朱国臣,肖大江,陈琦,朱雅维.鼻咽癌组织中EphA2的表达变化及其意义[J].临床耳鼻咽喉头颈外科杂志,2011,25(18):827-829. 被引量:6
  • 10Ishikawa M,Miyahara R,Sonobe M,et al.Higher expressionof EphA2 and ephrin-Al is related to favorableclinicopathological features in pathological stage I non-smallcell lung carcinoma.Lung Cancer,2012 ; 76C3):431-438.

二级参考文献36

  • 1Walker-Daniels J, Hess AR, Hendrix MJ, et al. Differential regulation of EphA2 in normal and malignant cells. Am J Pathol,2003 . 162(4) : 1037-1042.
  • 2Celec P. Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed Pharmacother, 2004 . 58 (6-7) : 3652 - 3671.
  • 3Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 1998 . 16 ( 1 ) : 225-260.
  • 4Davis S, Galen W, Aldrich TH, et al. Ligands for EPH- related receptor tyrosine kinases that require membraneattachment or clustering for activity. Science, 1994; 266 (5186) :816-819.
  • 5Yalladares A, Hemandez NG, Gomez FS, et al. Genetic expression profiles and chromoeomal altemalions in sporadic breast cancer in Mexican wometl. Cancer Genet Cytogenet, 2006 .170(2) : 147-151.
  • 6Yamaguchi S, Tatsumi T, Takehara T, et al. Immunotherapy of murine colon cancer using receptor tymsine kinase EphA2-derived pepfide pulsed dendritic cell vaccines. Cancer,2007;110 (7) : 1469-1477.
  • 7Abraham S, Knapp DW, Cheng L, etal. Expression of EpbA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res,2006; 12(2) :353-360.
  • 8Straume O, Akslen LA. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/ fibroblast growth factor receptor-1 and Ephrin-A1/EphA2 on melanoma progression. Am J Pathol,2002. 160(3): 1009-1019.
  • 9Miyazaki T, Kato H, Fukuchi M, et al. EphA2 overexpression oerrelates with poor prognosis in esophageal squamous cell cacrinoma. Int J Cancer, 2003 ; 103(5) :657-663.
  • 10Choik K, Creighton CJ, Silvers D, et al. Transcriptional profiling of non small cell lung cancer ceils with activating EGFR somatic mutations. PLoS One,2007 ;2(11) :e1226.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部